Core Insights - Hongchang Technology (301008) has engaged in discussions with numerous institutions, including Jiufang Zhitu, Changxin Fund, Pacific Insurance, and Guotai Haitong, to address investor concerns regarding its investment in quality joints [1][2] - The company has established partnerships with several domestic humanoid robot companies, leveraging the founder's 20 years of experience in the reducer industry to gain a competitive edge in customer expansion [1] - Hongchang Technology has committed to investing in the humanoid robot sector, particularly in joints and reducers, which represent a significant cost within the industry, due to the promising growth potential of the robotics supply chain [1][2] Investment Strategy - In the first half of the year, Hongchang Technology has completed two rounds of capital increases in Quality Joints, totaling 30 million yuan, resulting in a 30% ownership stake [2] - The company aims to integrate both organic growth and external acquisitions as part of its established development strategy, with successful investments already made in Quality Joints and ongoing progress in acquisition funds [2] - Future focus will remain on identifying acquisition opportunities in industries with strong growth prospects and stable revenue and profit scales [2]